Suppr超能文献

CT在确定化疗前后肝母细胞瘤可切除性方面的价值。

Value of CT in determining the resectability of hepatoblastoma before and after chemotherapy.

作者信息

King S J, Babyn P S, Greenberg M L, Phillips M J, Filler R M

机构信息

Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

AJR Am J Roentgenol. 1993 Apr;160(4):793-8. doi: 10.2214/ajr.160.4.8384403.

Abstract

OBJECTIVE

The purpose of this study was to assess the accuracy of CT for determining surgical resectability of hepatoblastoma before and after chemotherapy.

MATERIALS AND METHODS

Preoperative and postoperative CT scans of 15 children with surgically confirmed hepatoblastoma were retrospectively reviewed and correlated with surgical findings and pathologic analysis.

RESULTS

Before chemotherapy, 12 of the 15 children had unresectable tumors because of bilobar involvement, metastatic disease, or vascular extension. After chemotherapy, tumor volumes decreased by 20-98%, with increased areas of low attenuation and calcification. Periportal areas of low attenuation (four of nine), abdominal adenopathy (four of four), and lung nodules (four of six) disappeared after chemotherapy. On the basis of CT and clinical findings, all tumors were thought to be resectable. Surgical correlation showed that the extent of hepatic tumor had been overestimated on immediate preoperative CT scans in three children (tumor was staged as bilobar, but only single-lobe resection was required). Correlation between areas of low attenuation in the tumor and necrosis in pathologic specimens was poor. Tumor invasion of periportal lymphatics was seen in one of five children with periportal areas of low attenuation. Postoperatively, five of 13 children had CT abnormalities, three at the resection margins with calcification, low attenuation, or both. Hepatic or abdominal disease has not recurred, and 12 of the 14 children who survived surgery are well. One child who had abnormal findings on preoperative chest CT died of pulmonary metastases. Another in whom chemotherapy was limited because of toxic effects died after tumor recurred in the liver.

CONCLUSION

Pretreatment CT scans cannot be used to predict ultimate resectability of hepatic tumors; nor are preoperative scans always accurate for judging exact lobar involvement. Absence of disease as shown on CT scans correlated with absence both at surgery and at follow-up. Postoperative hepatic changes are common and do not necessarily reflect recurrent or residual tumor.

摘要

目的

本研究旨在评估CT在确定化疗前后肝母细胞瘤手术可切除性方面的准确性。

材料与方法

回顾性分析15例经手术确诊的肝母细胞瘤患儿的术前和术后CT扫描结果,并与手术结果及病理分析进行对照。

结果

化疗前,15例患儿中有12例因双侧受累、转移性疾病或血管侵犯而无法切除肿瘤。化疗后,肿瘤体积缩小20% - 98%,低密度区和钙化区增加。化疗后,门静脉周围低密度区(9例中的4例)、腹部淋巴结肿大(4例中的4例)和肺结节(6例中的4例)消失。根据CT和临床检查结果,所有肿瘤均被认为可切除。手术对照显示,3例患儿术前即刻CT扫描高估了肝肿瘤范围(肿瘤被分期为双侧,但仅需单叶切除)。肿瘤内低密度区与病理标本中坏死之间的相关性较差。在5例门静脉周围有低密度区的患儿中,有1例可见肿瘤侵犯门静脉周围淋巴管。术后,13例患儿中有5例CT检查异常,3例在切除边缘有钙化、低密度或两者皆有。肝脏或腹部疾病未复发,14例手术存活患儿中有12例情况良好。1例术前胸部CT检查有异常的患儿死于肺转移。另1例因毒性作用化疗受限的患儿在肝脏肿瘤复发后死亡。

结论

治疗前CT扫描不能用于预测肝肿瘤的最终可切除性;术前扫描也并非总能准确判断确切的肝叶受累情况。CT扫描显示无疾病与手术及随访时均无疾病相关。术后肝脏改变常见,不一定反映肿瘤复发或残留。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验